Bio Techne | TECH - Fremdkapital

Aktienkurs
55.11
Täglich Wechseln
0.93 1.71%
Monatlich
5.90%
Jährlich
9.67%
Q2 Prognose
53.03




Fremdkapital Veränderung Datum
Agilent USD 3.05B 0 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bio Techne USD 260M 40M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Bruker USD 1.85B 131.7M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Danaher USD 17.56B 855M 2026-03
Illumina USD 1.49B 496M 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Merck EUR 10.73B 277M 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Standard Biotools USD 299K 0 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Waters USD 1.41B 460.24M 2025-12